Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Freenome Holdings Inc.
Age
30–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age at least 30 years
Able and willing to provide blood samples per protocol
Able to comprehend and willing to sign and date the informed consent documents
Participants must meet one of the following:
* Diagnosed with a single primary cancer that has not yet been treated
* No evidence or treatment of any cancer for at least 5 years prior to enrollment
You may not be if
A medical condition which, in the opinion of the investigator, should preclude enrollment in the study
Known to be pregnant
Any therapy for cancer, including surgery, chemotherapy, immunotherapy, and/or radiation therapy in the 5 years preceding enrollment
Participated or currently participating in a clinical research study in which an experimental medication has been administered in the last 30 days
Participated in or currently participating in another Freenome clinical study
For the control cohort: Any previous cancer diagnosis in the 5 years preceding enrollment, or recurrence of the same primary cancer within any timeframe; or concurrent diagnosis of multiple primary cancers within any timeframe
For the cancer cohorts: Any previous cancer diagnosis in the 5 years preceding enrollment, apart from the current cancer diagnosis; OR recurrence of the same primary cancer within any timeframe; OR concurrent diagnosis of multiple primary cancers within any timeframe
Clareo Health | The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
